Reactive, hastily enforced regulations can easily jeopardize the sound conduct of a clinical trial and its data flow, potentially threatening both subject safety and data quality.
Susan Shelby, PhD
Advertisement
Articles by Susan Shelby, PhD
Advertisement
Latest Updated Articles
- Data Privacy Concerns Between EU-US Intensifies
Published: February 9th 2016 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Drug Repurposing Through AI-Driven In-Silico Clinical Trials
2
Voyxact Lands FDA Accelerated Approval Following Positive Results in Phase III VISIONARY Trial
3
Former FDA Commissioners Warn New Vaccine Policies Could Undermine Longstanding Regulatory Framework
4
ACT Brief: CNS Trial Expansion, Vaccine Policy Debate, and New Leadership at FDA
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
